References

Adeno-associated virus capsid assembly is divergent and stochastic

10.1038/s41467-021-21935-5 · 2021 · External reference

Characterization of Adeno-Associated Virus Capsid Proteins with Two Types of VP3-Related Components by Capillary Gel Electrophoresis and Mass Spectrometry

2021 · External reference

Effect of Genome Size on AAV Vector Packaging

10.1038/mt.2009.255 · 2010 · External reference

Gene Therapy Using Adeno-Associated Virus Vectors

10.1128/cmr.00008-08 · 2008 · External reference

Engineering adeno-associated viruses for clinical gene therapy

10.1038/nrg3742 · 2014 · External reference

Cryo-electron Microscopy of Adeno-associated Virus

10.1021/acs.chemrev.1c00936 · 2022 · External reference

The Expression and Function of the Small Nonstructural Proteins of Adeno-Associated Viruses (AAVs)

10.3390/v16081215 · 2024 · External reference

Gene Therapy Advances: A Meta-Analysis of AAV Usage in Clinical Settings

2021 · External reference

The state of cell and gene therapy in 2023

10.1016/j.ymthe.2023.11.001 · 2023 · External reference

AAV vector development, back to the future

10.1016/j.ymthe.2025.03.064 · 2025 · External reference

Urgent call to action: Making gene therapy for Duchenne muscular dystrophy (DMD) affordable and accessible

10.1111/bcp.15900 · 2023 · External reference

Viral vector-based gene therapies in the clinic

10.1002/btm2.10258 · 2022 · External reference

rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis

10.3389/fimmu.2022.1001263 · 2022 · External reference

Characterization of AAV vectors: A review of analytical techniques and critical quality attributes

10.1016/j.omtm.2024.101309 · 2024 · External reference

Process and quality considerations for recombinant adeno-associated virus manufacturing platforms

10.1016/j.tibtech.2025.02.016 · 2025 · External reference

Towards a Platform Chromatography Purification Process for Adeno-Associated Virus (AAV)

10.1002/biot.202400526 · 2025 · External reference

Chromatography in Downstream Processing of Recombinant Adeno-Associated Viruses: A Review of Current and Future Practises

10.1002/bit.28932 · 2025 · External reference

Downstream processing of AAV based gene therapy vectors

10.1016/j.seppur.2025.133051 · 2025 · External reference

Development of an HEK293 Suspension Cell Culture Medium, Transient Transfection Optimization Workflow, and Analytics for Batch rAAV Manufacturing

10.1002/bit.28980 · 2025 · External reference

Improved productivity of recombinant adeno-associated virus (rAAV) via triple transfection of HEK293 cells using perfusion cultivation

10.1007/s00449-025-03167-9 · 2025 · External reference

Significant differences in capsid properties and potency between AAV vectors produced in Sf9 and HEK293 cells

10.1089/hum.2022.116 · 2023 · External reference

Systematic comparison of rAAV vectors manufactured using large-scale suspension cultures of Sf9 and HEK293 cells

10.1016/j.ymthe.2023.11.022 · 2024 · External reference

Methods Matter: Standard Production Platforms for Recombinant AAV Produce Chemically and Functionally Distinct Vectors

10.1016/j.omtm.2020.05.018 · 2020 · External reference

Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells

10.1016/j.jviromet.2007.03.014 · 2007 · External reference

Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery

10.1016/j.jviromet.2013.10.038 · 2014 · External reference

Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the CultureMedia for GMP FIX and FLT1 Clinical Vector

10.1038/mt.2015.187 · 2016 · External reference

The state of technological advancement to address challenges in the manufacture of rAAV gene therapies

10.1016/j.biotechadv.2024.108433 · 2024 · External reference

Rational downstream development for adeno-associated virus full/empty capsid separation – A streamlined methodology based on high-throughput screening and mechanistic modeling

10.1016/j.chroma.2024.464632 · 2024 · External reference

Combining steric exclusion with anion exchange – development of a universal and scalable adeno-associated virus downstream process

10.1016/j.chroma.2025.465674 · 2025 · External reference

Consecutive Affinity and Ion-Exchange Chromatography for AAV9 Vectors Purification

10.3390/biomedicines13020361 · 2025 · External reference

Improved adeno-associated virus empty and full capsid separation using weak partitioning multi-column AEX chromatography

10.1002/biot.202300245 · 2024 · External reference

Purification of AAV8 through a scalable two-step monolithic chromatography approach

10.1016/j.chroma.2024.465586 · 2025 · External reference

High-yield recombinant adeno-associated viral vector production by multivariate optimization of bioprocess and transfection conditions

10.1002/btpr.3445 · 2024 · External reference

Tuning capsid formation dynamics in recombinant adeno-associated virus producing synthetic cell lines to enhance full particle productivity

10.1002/biot.202400051 · 2024 · External reference

Production of recombinant adeno-associated virus 5 using a novel self-attenuating adenovirus production platform

10.1016/j.omtm.2024.101320 · 2024 · External reference

Comparison of highly pure rAAV9 vector stocks produced in suspension by PEI transfection or HSV infection reveals striking quantitative and qualitative differences

10.1016/j.omtm.2021.12.006 · 2022 · External reference

Establishment of a novel human amniotic epithelial-derived cell line, HAT, for high-yield AAV vector production

10.1016/j.omtm.2025.101594 · 2025 · External reference

Creation of a High-Yield AAV Vector Production Platform in Suspension Cells Using a Design-of-Experiment Approach

10.1016/j.omtm.2020.06.004 · 2020 · External reference

Design space determination to optimize DNA complexation and full capsid formation in transient rAAV manufacturing

10.1002/bit.28508 · 2023 · External reference

Enhancing the production of adeno-associated virus (AAV)2 and AAV9 with high full capsid ratio in HEK293 cells through design-of-experiment optimization of triple plasmid ratio

10.1002/biot.202300667 · 2024 · External reference

Unlocking DOE potential by selectingthe most appropriate design for rAAV optimization

10.1016/j.omtm.2024.101329 · 2024 · External reference

Direct Identification and Quantification of Recombinant Adeno- Associated Virus in Crude Cell Lysate and Conditioned Medium by Mass Photometry

10.1021/acs.analchem.5c00793 · 2025 · External reference

Variation of VP2 stoichiometry and deamidation of VP1 during production and their impacts on the transduction efficiency of AAV vectors

10.1016/j.omtm.2025.101581 · 2025 · External reference

Combined 100 keV cryo-electron microscopy and image analysis methods to characterize the wider adeno-associated viral products

10.1016/j.xphs.2024.03.026 · 2024 · External reference

Enhancement of recombinant adeno-associatedvirus activity by improved stoichiometry and homogeneity of capsid protein assembly

10.1016/j.omtm.2023.101142 · 2023 · External reference

Use of cesium chloride density gradient ultracentrifugation for the purification and characterization of recombinant adeno-associated virus

10.1007/s00249-025-01751-1 · 2025 · External reference

Deamidation of Amino Acids on the Surface of Adeno-Associated Virus Capsids Leads to Charge Heterogeneity and Altered Vector Function

10.1016/j.ymthe.2018.09.013 · 2018 · External reference

Engineered Capsids for Efficient Gene Delivery to the Retina and Cornea

10.1089/hum.2020.070 · 2020 · External reference

Differential T cell immune responses to deamidated adeno-associated virus vector

10.1016/j.omtm.2022.01.005 · 2022 · External reference

Focused Differential Glycan Analysis with the Platform Antibody-assisted Lectin Profiling for Glycan-related Biomarker Verification

10.1074/mcp.m800308-mcp200 · 2009 · External reference

Glycosylation of recombinant adeno-associated virus serotype 6

10.1016/j.omtm.2024.101256 · 2024 · External reference

Analytical Dissection of Minor Glycoforms and Glycoprotein Associations in rAAV Preparations by Multimodal Glycoproteomics

10.1007/s00216-025-06042-4 · 2025 · External reference

Lethal immunotoxicityin high-dose systemic AAV therapy

10.1016/j.ymthe.2023.10.015 · 2023 · External reference

Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne’s Muscular Dystrophy

10.1056/nejmoa2307798 · 2023 · External reference

Empty virions in AAV8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side effects

10.1038/mtm.2013.9 · 2014 · External reference

Comparison of Different Liquid Chromatography-Based Purification Strategies for Adeno-Associated Virus Vectors

10.3390/pharmaceutics13050748 · 2021 · External reference

Manufacturing challenges and rational formulation development for AAV viral vectors

10.1016/j.xphs.2021.03.024 · 2021 · External reference

Unraveling Cytotoxicity in HEK293 Cells During Recombinant AAV Production for Gene Therapy Applications

10.1002/biot.202400501 · 2025 · External reference

Adeno-associated virus perfusion enhanced expression: A commercially scalable, hightiter, high quality producer cell line process

10.1016/j.omtm.2024.101266 · 2024 · External reference

Multi-omics kinetic analysis of recombinant adeno-associated virus production by plasmid transfection of HEK293 cells

10.1002/btpr.3428 · 2024 · External reference

Comparative transcriptomic and proteomic kinetic analysis of adeno-associated virus production systems

10.1007/s00253-024-13203-5 · 2024 · External reference

Adeno-associated virus vector system controlling capsid expression improves viral quantity and quality

10.1016/j.isci.2023.106487 · 2023 · External reference

Unfolding of viral protein 1 N-termini facilitates genome ejection from recombinant adeno-associated virus serotype 8

10.1016/j.omtm.2025.101480 · 2025 · External reference

Size Distribution Analysis of the Adeno-Associated Virus Vector by the c(s) Analysis of Band Sedimentation Analytical Ultracentrifugation with Multiwavelength Detection

10.1016/j.xphs.2022.10.023 · 2023 · External reference

Sedimentation Analysis of Noninteracting and Self-Associating Solutes Using Numerical Solutions to the Lamm Equation

10.1016/s0006-3495(98)74069-x · 1998 · External reference

Computer-aided interpretation of analytical sedimentation data for proteins

1992 · External reference

Comprehensive Size Distribution and Composition Analysis of Adeno-Associated Virus Vector by Multiwavelength Sedimentation Velocity Analytical Ultracentrifugation

10.1016/j.xphs.2021.06.031 · 2021 · External reference

Multimass Analysis of Adeno-Associated Virus Vectors by Orbitrap-Based Charge Detection Mass Spectrometry

10.1021/acs.analchem.4c05229 · 2024 · External reference

Recombinant AAV batch profiling by nanoporesequencing elucidates product-related DNAimpurities and vector genome length distribution

10.1016/j.omtm.2025.101417 · 2025 · External reference

A novel protocol for in-depth analysis of recombinant adeno-associated virus capsid proteins using UHPLC–MS/MS

10.1002/rcm.9247 · 2022 · External reference

An AsCas12f-based compact genome-editing tool derived by deep mutational scanning and structural analysis

10.1016/j.cell.2023.08.031 · 2023 · External reference